Breaking News on Contract Research, Manufacturing & Clinical Trials

Big Sponsors > Merck & Co

Europe delays Merck & Co.'s HCV drug on back of CMO quality issues

09-May-2016 - Inadequate record keeping at Merck & Co.’s contract manufacturer has delayed the European launch of its hepatitis C drug Zepatier (elbasvir and grazoprevir).

Merck expands deal with 'organ-on-chip' tech firm Emulate

06-Jan-2016 - Merck & Co. has expanded a partnership to use Emulate’s organ-on-chip technology to carry out predictive modelling of inflammatory processes.

Roche: Small molecule exit will lead to outsourcing opportunities

16-Nov-2015 - Roche’s exit from four small molecule manufacturing plants will provide opportunities for third-party manufacturers, the firm says.

CPhI Worldwide 2015

Rush to acquire ex-pharma sites means survival of the biggest for CMOs

22-Oct-2015 - As pharma sells off manufacturing capacity and outsources to large and specialist CMOs, smart contract houses will have an opportunity to grab market share in a currently fragmented sector, say...

Aesica and Merck & Co. to benefit from green energy cost-savings in UK

23-Sep-2015 - Electricity from a ‘green energy’ biomass plant being built nearby will cut utility costs at an Aesica UK facility and help the CDMO stay competitive.

Bavarian Nordic wins up to $33m to develop J&J Ebola vaccine

16-Sep-2015 - Danish biotech Bavarian Nordic has signed a $9m contract from Johnson & Johnson to improve stability of their joint Ebola vaccine. After options and milestone awards, payment could total $33m.

News in brief

Merck recalls 276,000 pill bottles

20-Aug-2015 - Merck & Co. has recalled two chemotherapy products because of cracked caps, including one it manufactures for Novartis’ Sandoz.

Antiquated clinical trial industry ripe for change from innovation, experts say

15-May-2015 - Experts across the sponsor-CRO spectrum seem to agree on at least one thing: the clinical trial process is ready for a major transformation, though how quickly and what types of...

Dispatches from PCT US

TransCelerate CEO, leaders offer update on industry group’s activities

27-Apr-2015 - As 20 of the largest biopharma companies have now joined industry group TransCelerate, the group is beginning to use patient centricity and connectivity to influence the clinical trial environment, CEO...

Merck 'bio-inks' deal to use Organovo's 3D printed liver for preclinical studies

23-Apr-2015 - Merck & Co. has struck a deal with Organovo to use a 3D printed human liver system for toxicology testing as a supplement to in vitro and preclinical animal testing....

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told the preclinical CRO may add scale to US...

Novartis to close Puerto Rico plant and outsource to Eli Lilly

19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.

India calls for post-marketing data on cancer drugs approved without local trials

06-Jan-2015 - More than a year since its creation , India’s Apex Committee is now calling for developers of cancer treatments approved without trials in India to monitor the first 500 patients to...

UK Hospitals to play part in Gov efforts to speed clinical trial process

20-Nov-2014 - UK life sciences minister George Freeman wants hospitals to play more of a role in clinical trials and says accelerating the drug development process in the post block-buster era is...

Mega deals like Merck-Sigma cut biopharma bargaining power says leading CMO

24-Sep-2014 - Life science sector consolidation is a concern for some biomanufacturers, who say mega mergers like Merck KGaA’s $17bn acquisition of Sigma-Aldrich will limit their ability to negotiate on prices.

Merck Millipore says Indian lab can boost generics quality

07-Jul-2014 - Merck Millipore, the life sciences tools division of Merck KGaA, has launched a solid dose formulation lab in India, its first outside Europe.

Merck & Co. contracts Catalent to make sublingual hayfever drugs

23-Apr-2014 - MSD has selected Catalent to manufacture two recently approved sublingual pollen extract drugs using its Zydis formulation platform.

Columbia Labs Q4: Lumpy Merck sales and loss of Actavis contract mars strong year

06-Mar-2014 - Columbia Laboratories has reported strong annual results despite a fourth quarter affected by Actavis taking the manufacture of vaginal gel Crinone in-house and the “lumpiness” of Merck Serono.

Packaging fault takes Merck's Liptruzet off US market for foreseeable future

15-Jan-2014 - The combination cholesterol drug Liptruzet will be unavailable in the US for the foreseeable future, says Merck & Co., after packaging defect at CMO led to a total product recall.

Merck Millipore sells its discovery and development service biz to Eurofins

09-Jan-2014 - Merck Millipore has sold its Discovery and Development Solutions (DDS) Business to Eurofins saying it was unable to fully support.

Dispatches from PCT

Quintiles is the "arms, legs and brain" in Merck Serono's monogamous relationship

02-Dec-2013 - Trust, transparency and end-to-end participation are just some of the reasons Merck Serono says its exclusive strategic partnership with Quintiles is the “first of its kind.”

Merck & Co. Ups Russian Contract to Appease Pharma 2020

20-Aug-2013 - MSD has extended its branded drug manufacturing partnership with Akrikhin in order to fulfill Pharma 2020 - Russia’s local manufacturing strategy.

Aspen Acquires Merck’s Dutch API Plant for $1B

01-Jul-2013 - The Aspen Group, a generic pharmaceutical company, is moving further into the manufacturing business with the purchase of Merck’s API manufacturing sites in the Netherlands and Iowa.

Quintiles Signs Exclusive Development Deal with Merck Days After $1B IPO

16-May-2013 - Just days after raising more than $1B in its IPO, Quintiles announced Wednesday it signed a five-year clinical development agreement with Merck Serono. 

Dispatches from Outsourcing in Clinical Trials East Coast, Philadelphia

Merck, Eisai Reap Savings from Off-Shoring, Outsourcing in China and India

20-Mar-2013 - Drugmakers Merck & Co and Eisai have both substantially cut internal data management costs through two unique off-shoring operations in China and India, respectively.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...